<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-048031</identifier>
<setSpec>0003-3170</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The radiation dose received by patients during endovascular treatment of abdominal aortic aneurysms</dc:title>
<dc:description xml:lang="en">Introduction. It is becoming increasingly more frequent to treat abdominal aortic aneurysms (AAA) using    endovascular techniques and as a result the doses of radiation patients receive, both in the diagnosis and intervention as    well as in the ensuing follow-up, are higher than in conventional surgical treatment. It is essential to define the reference    radiation dosage levels that are needed to perform the operation. Aim. To quantify the total dose received by patients    submitted to this kind of treatment. Patients and methods. An observational-prospective study was conducted to analyse    46 patients with AAA who were treated using an endovascular approach in the year 2004; aortomonoiliac devices were    utilised in 27 cases and 19 received bifurcated stents. Results. A total radiation dose of 48.62 mSv was obtained in the    first year; patients received the same dose regardless of whether an aortomonoiliac or a bifurcated stent had been    placed. Conclusions. The dose obtained does not give rise to any appreciable adverse effects in the first year as far as    dosage-determined effects are concerned. The greater part of the dose received by patients is due to the computerised    axial tomography scans that are carried out. Magnetic resonance imaging can play an important role in reducing the    doses that are required in the future</dc:description>
<dc:creator>Fernández Alonso, S</dc:creator>
<dc:creator>Riera Del Moral, Luis Felipe</dc:creator>
<dc:creator>Mendieta Azcona, Covadonga</dc:creator>
<dc:creator>Sáez Martín, Luis</dc:creator>
<dc:creator>Leblic Ramírez, Israel</dc:creator>
<dc:creator>Stefanov Kiuri, Stefan</dc:creator>
<dc:creator>Garzón Moll, Gonzalo</dc:creator>
<dc:creator>Fernández Heredero, Álvaro</dc:creator>
<dc:creator>Gutiérrez Nistal, Marta</dc:creator>
<dc:creator>Riera de Cubas, Luis</dc:creator>
<dc:creator>Corredoira Silva, E</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. Las técnicas endovasculares se utilizan cada vez con mayor frecuencia en el tratamiento de los    aneurismas de aorta abdominal (AAA), para lo que es necesario emplear mayores dosis de radiación en los pacientes,    tanto en el diagnóstico como en el procedimiento y su seguimiento posterior, que en el tratamiento quirúrgico convencional.    Es imprescindible delimitar los niveles de referencia de dosis de radiación necesarios para la ejecución del procedimiento.    Objetivo. Cuantificar la dosis total que reciben los pacientes sometidos a esta modalidad de tratamiento. Pacientes    y métodos. Se analiza de forma observacional-prospectiva a 46 pacientes con AAA tratados mediante abordaje endovascular    en el año 2004, de los cuales 27 reciben un montaje aortomonoilíaco y 19 bifurcado. Resultados. Se obtiene una    dosis de radiación total de 48,62 mSv el primer año; esta dosis no difiere entre los pacientes a los que se les coloca una    endoprótesis aortomonoilíaca o una bifurcada. Conclusiones. La dosis obtenida no produce un efecto nocivo apreciable    el primer año en lo que respecta a efectos deterministas de la dosis empleada. La mayor parte de la dosis recibida se debe    a los estudios con tomografía axial computarizada. La resonancia magnética puede jugar un papel muy importante para    la reducción de la dosis necesaria en el futuro</dc:description>
<dc:source>Angiologia;58(4): 311-319, jul.-ago. 2006. ilus, tab</dc:source>
<dc:identifier>ibc-048031</dc:identifier>
<dc:title xml:lang="es">Dosis de radiación recibida por el paciente durante el tratamiento endovascular de los aneurismas de aorta abdominal</dc:title>
<dc:subject>^d794^s22067</dc:subject>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d794^s22059</dc:subject>
<dc:subject>^d794^s22016</dc:subject>
<dc:subject>^d12268</dc:subject>
<dc:subject>^d1017^s22022</dc:subject>
<dc:subject>^d23232^s22045</dc:subject>
<dc:subject>^d9396^s22045</dc:subject>
<dc:subject>^d11916^s22074</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1017^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>200608</dc:date>
</metadata>
</record>
</ibecs-document>
